A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine
PHASE2CompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
January 31, 1998
Study Completion Date
November 30, 2001
Conditions
HIV Infection
Interventions
DRUG
Ritonavir
DRUG
Nevirapine
DRUG
Stavudine
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001688 - A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine | Biotech Hunter | Biotech Hunter